文章摘要

硫氧还蛋白与肺部疾病的研究进展

作者: 1黄蜜, 2戴爱国, 2蒋永亮
1 南华大学附属省马王堆医院,长沙 410016;湖南省老年医院呼吸疾病研究室,长沙 410016
2 湖南省老年医院呼吸疾病研究室,长沙 410016
通讯: 戴爱国 Email: daiaiguo2003@163.com
DOI: 10.3978/j.issn.2095-6959.2014.05.030
基金: 湖南省科技计划项目, B2014-075 湖南省科技计划重点项目, 2012SK2006 湖南省科技计划项目

摘要

硫氧还蛋白系统是一个广泛存在于自然界的巯基氧化还原系统,它能够维持细胞的氧化还原动态 平衡及阻止炎症反应的发生。它由硫氧还蛋白(thioredoxin,Trx)、硫氧还蛋白还原酶(thioredoxin reductase,TrxR)和还原型辅酶II(reduced coenzyme II,NADPH)三部分组成。人类Trx作为一种分 泌性蛋白,在细胞内外发挥着多种氧化还原调控作用。Trx通过直接抑制氧化应激和间接与关键信 号转导分子结合而发挥了抗氧化、抗凋亡和抗炎症作用。最近的研究显示Trx作为机体内主要的氧 化应激相关因子,可能在肺部疾病中发挥了一定作用,且有可能成为临床干预治疗的靶点。本文 对Trx在呼吸系统的表达与慢性阻塞性肺疾病、支气管哮喘、急性肺损伤(acute lung disease,ALI) 和间质性肺疾病(interstitial lung disease,ILD)的关系进行简述。
关键词: 硫氧还蛋白 氧化应激 炎症 肺部疾病

Recent progress of thioredoxin and lung-related diseases

Authors: 1HUANG Mi, 2DAI Aiguo, 2JIANG Yongliang
1 Provincial Mawangdui Hospital Affiliated to University of South China, Changsha 410016; Hunan Province Gerontology Research Institute, Changsha 410016, China
2 Hunan Province Gerontology Research Institute, Changsha 410016, China

CorrespondingAuthor: DAI Aiguo Email: daiaiguo2003@163.com

DOI: 10.3978/j.issn.2095-6959.2014.05.030

Abstract

Thioredoxin system is a ubiquitous thiol oxidoreductase system, it can be a regulator of cellular redox homeostasis and prevent cellular inflammation. It comprises of thioredoxin (Trx), thioredoxinreductase (TrxR) and reduced coenzyme II (NADPH). Human thioredoxin, originally identified as a secretory protein and played a wide variety of redox regulations in both intracellular and extracellular compartments. Trx plays an essential role by limiting oxidative stress directly and indirectly by proteins interaction with key signal transduction molecules with antioxidant, anti-apoptosis and anti-inflammation effects. Recent studies indicated that thioredoxin as a main oxidative stress-related factor may place a role in the pathogenesis of lung-related diseases and be the target of intervention therapy. This paper reviewed the relationship of thioredoxin and chronic obstructive pulmonary disease, asthma, acute lung injury, and interstitial lung diseases.

文章选项